This trial is active, not recruiting.

Condition polycystic ovary syndrome
Treatments acupuncture, sham acupuncture
Sponsor University of Virginia
Start date January 2006
End date December 2009
Trial size 78 participants
Trial identifier NCT00602940, 12045, NIH R21 AT002520


This is a randomized control trial of acupuncture for women with polycystic ovary syndrome. The study is triple-blinded.

United States No locations recruiting
Other countries No locations recruiting

Study Design

Allocation randomized
Intervention model parallel assignment
Masking double blind (subject, investigator, outcomes assessor)
Primary purpose treatment
Active acupuncture treatment
12 treatments over 8 weeks
(Sham Comparator)
Sham acupuncture treatment
sham acupuncture
12 treatments over 8 weeks

Primary Outcomes

ovulation in 2 out of 5 months of study participation
time frame: monthly

Secondary Outcomes

changes in follicle stimulating hormone and luteinizing hormone
time frame: baseline vs. 2 months vs. 5 months

Eligibility Criteria

Female participants from 18 years up to 43 years old.

Inclusion Criteria: - ages 18-43 - confirmation of PCOS through the study - signed informed consent - able to receive study treatment at Virginia study sites - agree not to use hormonal medications for the 5 months of the study Exclusion Criteria: - pregnant - use of hormonal drugs 30/60 days before the study entry - acupuncture for ovulatory disorders 30 days prior to study entry

Additional Information

Official title The Influence of Acupuncture on Ovulation and Reproductive Hormones
Principal investigator Lisa M Pastore, PhD
Trial information was received from ClinicalTrials.gov and was last updated in May 2010.
Information provided to ClinicalTrials.gov by University of Virginia.